Multiple sclerosis patients who followed a ketogenic diet experienced less fatigue, improved symptoms of depression, and improved quality of life. Additionally, those who followed a keto diet had reduced levels of inflammatory markers in blood samples.
Study reaffirms findings that the gut microbiome may play a significant role in cognitive decline. Researchers found, in mice, a ketogenic diet, hypoxia, and the Bilophila wadsworthia bacteria impaired the hippocampus, leading to signs of cognitive decline.
K.Vita, a new oral dietary substance based on the ketogenic diet, reduced seizures by up to 50% in children and adults with drug-resistant epilepsy.
Following the Mediterranean ketogenic diet can help modulate unique fungi found in the gut of those with mild cognitive impairment.
In the short term, a ketogenic diet can help improve health as well as assist in weight loss. However, the negative effects of the keto diet start to appear after one week. Mice who were fed a ketogenic-style diet for more than seven days consumed more fat than they could burn, and had an increased risk of developing diabetes and obesity.
Male fruit flies fed a ketone supplemented diet expressed reduced levels of aggression following concussion than those who were not exposed to the dietary intervention.
A modified Mediterranean-ketogenic diet can modulate the gut microbiome and metabolites associated with improvements in Alzheimer's disease biomarkers.
Genetic testing can help identify children at risk of epilepsy, in addition to identifying new genetic mutations associated with the condition. Using CBD based medications can also help reduce seizures in children with epilepsy.
A small scale pilot study reveals adults with mild cognitive impairment may have improved brain function and memory when they switch to a high-fat, low-carb diet.
Combining an antibiotic drug that targets glutamine with the ketogenic diet helps kill glioblastoma cancer cells, reversing symptoms of the disease and improving survivability in mouse models.
Mimicking effects of the ketogenic diet with a drug called 2-DG reduced cell excitation and epileptic activity in mouse models of post-traumatic epilepsy. 2-DG may have the potential to restore network function following TBI, reducing the risk of epilepsy associated with head injuries. The findings may have positive implications for people who developed post-traumatic epilepsy, suggesting a change in diet could help alleviate some symptoms.
Researchers report our gender can determine longevity and response to treatment for glioblastoma brain cancer. The study reports male survival is determined by genes that control cell division, where as female survival is often determine by genes that regulate the ability of cancer cells to migrate to different brain areas.